Tag Archives: SAGE

Top 5 Warren Buffett Stocks To Invest In Right Now

Berkshire Hathaway(NYSE:BRK-A) (NYSE:BRK-B) held its annual meeting last weekend. In this episode of MarketFoolery, host Chris Hill talks with special guest Matt Koppenheffer of Fool Germany about some Volkswagen, some Tesla (NASDAQ:TSLA), and a whole lot of Berkshire. Berkshire just got really interested in Apple (NASDAQ:AAPL), but how is this different from the company’s ill-fated investment in IBM (NYSE:IBM)?

Warren Buffett and Elon Musk took to some verbal sparring about the importance of moats and the ease of running a candy company. Berkshire’s HomeServices branched into Berlin, setting the massive company up for even more growth down the road. Volkswagen is back in the news lately, and it’s still not for anything good — but its stock tells a different story. Tune in to find out more.

A full transcript follows the video.

This video was recorded on May 8, 2018.

Chris Hill: It’sTuesday, May 8th. Welcome to MarketFoolery! I’m Chris Hill. Special guestin the studio today, and by special, I mean,he comes by about once a year. From Fool Germany, it’sMatt Koppenheffer. Good to see you!

Top 5 Warren Buffett Stocks To Invest In Right Now: Energy Fuels Inc(UUUU)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 2,265,513 shares, an increase of 19.6% from the May 31st total of 1,893,582 shares. Based on an average daily volume of 589,166 shares, the days-to-cover ratio is presently 3.8 days. Approximately 3.3% of the shares of the stock are short sold.

  • [By Stephan Byrd]

    Energy Fuels (NYSEAMERICAN:UUUU) (TSE:EFR) shares saw an uptick in trading volume on Monday . 1,091,365 shares were traded during mid-day trading, an increase of 300% from the previous session’s volume of 272,846 shares.The stock last traded at $2.09 and had previously closed at $2.04.

  • [By Logan Wallace]

    Old West Investment Management LLC purchased a new stake in Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) in the first quarter, HoldingsChannel reports. The firm purchased 578,496 shares of the basic materials company’s stock, valued at approximately $1,003,000.

Top 5 Warren Buffett Stocks To Invest In Right Now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Sage Therapeutics (NASDAQ:SAGE) soared more than 20% today after the company announced that the U.S. Food and Drug Administration will allow an expedited development program for one of its most promising drug candidates.

  • [By Shane Hupp]

    SG Americas Securities LLC acquired a new position in SAGE Therapeutics Inc (NASDAQ:SAGE) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,233 shares of the biopharmaceutical company’s stock, valued at approximately $843,000.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on SAGE Therapeutics (SAGE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Warren Buffett Stocks To Invest In Right Now: SK TELECOM ADR EACH REP 1/9 KRW500(CIT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the news articles that may have effected Accern’s analysis:

    Get CIT Group alerts:

    Were winning the war on CIT heists, say police (citizen.co.za) Oppenheimer Equities Analysts Reduce Earnings Estimates for CIT Group (CIT) (americanbankingnews.com) Did Grandview police use their crisis training before fatally shooting man with sword? (kansascity.com) CIT Group (CIT) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com) CIT Adds New Executive to Communications & Technology Finance Team (abladvisor.com)

    Shares of CIT Group traded up $0.66, reaching $51.56, during midday trading on Friday, according to Marketbeat.com. The stock had a trading volume of 37,528 shares, compared to its average volume of 1,228,943. CIT Group has a one year low of $43.25 and a one year high of $56.14. The company has a market cap of $6.42 billion, a PE ratio of 16.76, a price-to-earnings-growth ratio of 1.27 and a beta of 1.28. The company has a debt-to-equity ratio of 1.53, a current ratio of 1.09 and a quick ratio of 1.09.

  • [By Joseph Griffin]

    These are some of the news headlines that may have effected Accern Sentiment’s rankings:

    Get CIT Group alerts:

    CIT Closes on $26.6MM Loan for Medical Buildings (abladvisor.com) CIT provides $26.6 mln to joint venture to buy medical buildings (pehub.com) As security companies and guards face off, a wave of crime hits cash vans (msn.com) CIT Announces Addition to Rail Division’s Senior Leadership Team (finance.yahoo.com) CIT Group (CIT) EVP Sells $90,791.60 in Stock (americanbankingnews.com)

    A number of equities research analysts have issued reports on the company. TheStreet downgraded CIT Group from a “b-” rating to a “c+” rating in a research note on Thursday, June 14th. BTIG Research restated a “buy” rating and set a $57.00 price target on shares of CIT Group in a research note on Wednesday, April 18th. ValuEngine downgraded CIT Group from a “buy” rating to a “hold” rating in a research note on Thursday, May 3rd. Zacks Investment Research downgraded CIT Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 6th. Finally, BMO Capital Markets cut their price target on CIT Group from $49.00 to $46.00 and set a “market perform” rating for the company in a research note on Wednesday, April 25th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and six have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $54.83.

  • [By Lee Jackson]

    This one may be somewhat more off the radar, but it is a top pick at Oppenheimer. CIT Group Inc. (NYSE: CIT) is a financial holding company with approximately $50 billion in assets as of March 31, 2018. Its principal bank subsidiary, CIT Bank, has approximately $30 billion of deposits and more than $40 billion of assets.

  • [By Joseph Griffin]

    Prudential Financial Inc. grew its stake in CIT Group (NYSE:CIT) by 496.6% during the first quarter, HoldingsChannel.com reports. The firm owned 308,179 shares of the financial services provider’s stock after purchasing an additional 256,526 shares during the quarter. Prudential Financial Inc.’s holdings in CIT Group were worth $15,871,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Joseph Griffin]

    Traders sold shares of CIT Group (NYSE:CIT) on strength during trading on Friday. $12.27 million flowed into the stock on the tick-up and $45.80 million flowed out of the stock on the tick-down, for a money net flow of $33.53 million out of the stock. Of all companies tracked, CIT Group had the 0th highest net out-flow for the day. CIT Group traded up $0.38 for the day and closed at $50.31

Top 5 Warren Buffett Stocks To Invest In Right Now: Saia Inc.(SAIA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Verition Fund Management LLC bought a new stake in Saia Inc (NASDAQ:SAIA) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 5,872 shares of the transportation company’s stock, valued at approximately $441,000.

  • [By Max Byerly]

    State of Tennessee Treasury Department trimmed its holdings in Saia Inc (NASDAQ:SAIA) by 9.5% during the first quarter, HoldingsChannel.com reports. The fund owned 17,868 shares of the transportation company’s stock after selling 1,877 shares during the period. State of Tennessee Treasury Department’s holdings in Saia were worth $1,343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Stephan Byrd]

    Saia (NASDAQ:SAIA) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Tuesday.

  • [By Stephan Byrd]

    Saia (NASDAQ: SAIA) and ArcBest (NASDAQ:ARCB) are both transportation companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk.

  • [By Ethan Ryder]

    Mesirow Financial Investment Management Equity Management trimmed its position in Saia (NASDAQ:SAIA) by 45.8% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 162,955 shares of the transportation company’s stock after selling 137,962 shares during the period. Mesirow Financial Investment Management Equity Management owned about 0.63% of Saia worth $12,246,000 as of its most recent SEC filing.

Top 5 Warren Buffett Stocks To Invest In Right Now: B&G Foods, Inc.(BGS)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of B&G Foods, Inc. (NYSE:BGS) have been given a consensus rating of “Hold” by the thirteen analysts that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $34.67.

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Stephan Byrd]

    Asset Management One Co. Ltd. trimmed its holdings in shares of B&G Foods, Inc. (NYSE:BGS) by 38.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 20,469 shares of the company’s stock after selling 12,949 shares during the period. Asset Management One Co. Ltd.’s holdings in B&G Foods were worth $485,000 at the end of the most recent reporting period.

  • [By ]

    B&G Foods (BGS) : “No, we’re going to stay away. This group is a snake pit.”

    Masco (MAS) : “I like Masco. We have a housing shortage and that’s good for Masco.”

  • [By ]

    B&G Foods (NYSE: BGS) Look in your pantry or your fridge or your freezer, there’s a better than 50% chance you got a couple of this company’s brands on the shelf. This $28 billion packaged food firm has been quietly acquiring old brands and breathing new and profitable life into them. Reviving stalwarts, such as Ortega, Cream of Wheat and Green Giant, and making headway with progressive, younger brands such as Skinny Girl and Pirate’s Booty (which my 16-year-old seems to live off), the company pulled in $1.6 billion in annual revenue last year while delivering a mind-boggling 24.7% return on equity. While officially a consumer staple stock, B&G is in growth mode through acquisition as displayed through its superior ROE. Shares trade at a 31% discount to their 52-week high. The stock trades at $28 (a 31with a forward PE of 13.41 and a compelling 6.78% dividend yield.

  • [By Max Byerly]

    B&G Foods (NYSE:BGS) has received a consensus rating of “Hold” from the twelve brokerages that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $34.38.

foreign investment

Gold Fields (NYSE: GFI) will, like all gold stocks, profit from rising gold prices. But Gold Fields will also perform well when gold prices remain stable or decline thanks to:

a strong balance sheet, the expected growth in production and the foreseen decline in its production costs. The Belgian Dentist and gold stocks

The archetypal Belgian dentist is known to be a “tax-efficient” investor. For years, a lot of gold stock IDRs (International Depositary Receipts) were quoted on the Belgian stock exchange. The fact that those IDRs were not registered, but bearer shares enabled the Belgian dentists to avoid paying dividend taxes. By the way, one of those IDRs was Gold Fields.

Time for value?

I’m not telling something new when I say that the US stock market is not cheap. The numbers in Exhibit 1 speak for themselves.

Exhibit 1: Worldwide valuations

foreign investment: Neptune Technologies & Bioresources Inc(NEPT)

Advisors’ Opinion:

  • [By William Romov]

    …or take a chance at 207% returns in just 49 days with penny stocks like Neptune Technologies & Bioressources Inc. (Nasdaq: NEPT)…

    …by the end of this step-by-step guide, you’ll know exactly how to do either on Ally’s discount online brokerage platform.

  • [By William Romov]

    …or take a chance at 207% returns in just 49 days with penny stocks like Neptune Technologies & Bioressources Inc. (Nasdaq: NEPT)…

    …these online discount brokers will allow you to do both.

foreign investment: Snap-On Incorporated(SNA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Swiss National Bank lowered its position in shares of Snap-on (NYSE:SNA) by 13.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 183,800 shares of the company’s stock after selling 29,700 shares during the quarter. Swiss National Bank owned 0.32% of Snap-on worth $27,118,000 as of its most recent filing with the SEC.

  • [By Dan Caplinger]

    Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven’t seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here’s why they did so well.

  • [By Joseph Griffin]

    Mountain Pacific Investment Advisers Inc. ID reduced its stake in Snap-on (NYSE:SNA) by 0.3% during the 1st quarter, HoldingsChannel.com reports. The firm owned 154,025 shares of the company’s stock after selling 440 shares during the quarter. Snap-on makes up approximately 2.3% of Mountain Pacific Investment Advisers Inc. ID’s holdings, making the stock its 14th biggest holding. Mountain Pacific Investment Advisers Inc. ID’s holdings in Snap-on were worth $22,725,000 at the end of the most recent reporting period.

foreign investment: Williams-Sonoma Inc.(WSM)

Advisors’ Opinion:

  • [By Daniel Miller]

    As major indices continue to trade near record highs it has become more difficult to hunt down valuable stocks at cheap prices. But if you can find those stocks, and if those stocks happen to boast a dividend yield of 3%, it gives investors an opportunity for solid returns at a time when many stocks are overpriced. Both Williams-Sonoma, Inc. (NYSE:WSM) and Ford Motor Company (NYSE:F) offer investors just that opportunity. Here’s why.

foreign investment: Citrix Systems Inc.(CTXS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    CIBC Asset Management Inc lowered its stake in shares of Citrix Systems (NASDAQ:CTXS) by 5.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,564 shares of the cloud computing company’s stock after selling 1,023 shares during the period. CIBC Asset Management Inc’s holdings in Citrix Systems were worth $1,816,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Asit Sharma]

    Stock in digital workspace systems providerCitrix Systems, Inc. (NASDAQ:CTXS) rose 10.8% inApril, according to data fromS&P Global Market Intelligence.

  • [By VantagePoint]

    Citrix Systems, Inc. (NASDAQ: CTXS) had a very clear crossover to the upside on April 11, and since that day's close the stock is up 15 percent. This one is interesting also because the two moving averages have also recently diverged even further, indicating that the uptrend has only gotten stronger since the company posted an excellent Q1 earnings and Q2 guidance report that came in well above Wall Street's expectations. 

foreign investment: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

foreign investment: VirnetX Holding Corp(VHC)

Advisors’ Opinion:

  • [By Paul Ausick]

    Late Tuesday, a federal court jury in the eastern district of Texas awarded VirnetX Holding Corp. (NYSEAMERICAN: VHC) $502.6 million in a case that VirnetX brought against Apple Inc. (NASDAQ: AAPL) regarding infringement of VirnetX patents and patented technology.

  • [By Stephan Byrd]

    VHC traded up $0.10 on Tuesday, hitting $4.10. 918,663 shares of the company were exchanged, compared to its average volume of 270,649. VirnetX has a 12 month low of $2.03 and a 12 month high of $8.75.

    ILLEGAL ACTIVITY NOTICE: “Short Interest in VirnetX Holding Co. (VHC) Expands By 1.2%” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3346516/short-interest-in-virnetx-holding-co-vhc-expands-by-1-2.html.

    About VirnetX

Hot China Stocks To Buy For 2018

In an announcement Tuesday morning from Shanghai, Ford Motor Co. (NYSE: F) said it had signed a memorandum of understanding with Chinese automaker Anhui Zotye Automobile to discuss the establishment of a 50-50 joint venture to develop, produce, market and service a new line of all-electric passenger vehicles (EVs) for the Chinese market.

Focusing on the market for electric vehicles in China leverages the country’s position as the world’s largest market for EVs due to government incentives aimed at curbing China’s massive air quality issues. Ford said it expects the market for EVs in China to rise to 4 million by 2025 out of a total of 6 million units that will have some degree of electrification.

Anhui Zotye has sold more than 16,000 EVs in the first seven months of 2017, an increase of 56% year over year. It is the Chinese market leader in the small all-electric vehicle segment.

Ford executive Peter Fleet said:

The potential to launch a new line of all-electric vehicles in the worlds largest auto market is an exciting next step for Ford in China. Electric vehicles will be a big part of the future in China and Ford wants to lead in delivering great solutions to customers.

Hot China Stocks To Buy For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

Hot China Stocks To Buy For 2018: TFS Financial Corporation(TFSL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on TFS Financial (TFSL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot China Stocks To Buy For 2018: ImmunoGen, Inc.(IMGN)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of the clinical-stage biotech ImmunoGen (NASDAQ:IMGN) rose by as much as 13.8% on heavy volume in early-morning trading today. The catalyst?

  • [By Brian Orelli]

    ImmunoGen (NASDAQ:IMGN) is in waiting mode with its lead drug, mirvetuximab, being tested in the phase 3 Forward I trial in patients with ovarian cancer, making for a relatively quiet first-quarter earnings release.

  • [By Logan Wallace]

    ImmunoGen (NASDAQ:IMGN) was downgraded by BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Wednesday.

  • [By Joseph Griffin]

    Trexquant Investment LP raised its stake in shares of ImmunoGen (NASDAQ:IMGN) by 190.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 331,215 shares of the biotechnology company’s stock after buying an additional 217,244 shares during the quarter. Trexquant Investment LP owned about 0.25% of ImmunoGen worth $3,484,000 at the end of the most recent reporting period.

Hot China Stocks To Buy For 2018: Methode Electronics, Inc.(MEI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

    Get Methode Electronics alerts:

    Analysts Expect Methode Electronics (MEI) Will Announce Quarterly Sales of $242.88 Million (americanbankingnews.com) Methode Electronics (MEI) Receives Consensus Recommendation of “Hold” from Brokerages (americanbankingnews.com) Analysts Anticipate Methode Electronics (MEI) Will Post Earnings of $0.74 Per Share (americanbankingnews.com) Commit To Buy Methode Electronics At $35, Earn 5.8% Annualized Using Options (nasdaq.com)

    Shares of Methode Electronics opened at $41.75 on Tuesday, Marketbeat reports. Methode Electronics has a 12-month low of $41.85 and a 12-month high of $42.60. The company has a market capitalization of $1.56 billion, a P/E ratio of 16.37, a price-to-earnings-growth ratio of 0.88 and a beta of 0.86. The company has a debt-to-equity ratio of 0.19, a current ratio of 4.03 and a quick ratio of 3.47.

  • [By Logan Wallace]

    ValuEngine cut shares of Methode Electronics (NYSE:MEI) from a hold rating to a sell rating in a research note published on Wednesday morning.

    MEI has been the topic of several other research reports. Zacks Investment Research lowered Methode Electronics from a buy rating to a hold rating in a research report on Saturday, February 24th. Robert W. Baird reissued an outperform rating and set a $51.00 target price (up previously from $48.00) on shares of Methode Electronics in a research report on Friday, March 2nd. Finally, TheStreet lowered Methode Electronics from a b rating to a c+ rating in a research report on Friday, March 2nd. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of $48.75.

Top 10 Medical Stocks To Invest In 2019

It can be hard to find great marijuana dividend stocks.

Medical marijuana was first legalized less than 20 years ago in California, so most cannabis companies haven’t been established long enough to make a profit, let alone pay a portion of their profits to shareholders in the form of dividends.

However, investors looking for marijuana stocks with dividends have another option…

Investing in marijuana “pick-and-shovel” plays that offer hefty dividends.

Pick-and-shovel plays allow you to benefit from an industry’s success without taking on the risk that comes with startups.

It’s like investing in Levi Strauss & Co. during the California Gold Rush of the 1840s and 50s. Levi’s didn’t mine gold, but it supplied the garments for the thousands of men who did.

The company’s slogan back then was even “For Men Who Toil.”

Since then, Levi Strass & Co. has become the largest pants manufacturer in the world.

Marijuana pick-and-shovel plays allow investors to profit from the legal pot industry without the risk of owning stock in a company whose product is still illegal under federal law. And because these stocks pay dividends, investors can reinvest their cash rewards to maximize their future returns.

Top 10 Medical Stocks To Invest In 2019: Integrated Device Technology, Inc.(IDTI)

Advisors’ Opinion:

  • [By Ezra Schwarzbaum]

    Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

    Lumentum Holdings Inc (NASDAQ: LITE)
    Ciena Corporation (NYSE: CIEN)
    Coherent, Inc. (NASDAQ: COHR)
    II-VI, Inc. (NASDAQ: IIVI)
    Inphi Corporation (NYSE: IPHI)
    Skyworks Solutions Inc (NASDAQ: SWKS)
    Integrated Device Technology Inc (NASDAQ: IDTI)
    Qorvo Inc (NASDAQ: QRVO)
    Xilinx, Inc. (NASDAQ: XLNX)
    Broadcom Inc (NASDAQ: AVGO)

    Related Links:

Top 10 Medical Stocks To Invest In 2019: Netease.com Inc.(NTES)

Advisors’ Opinion:

  • [By Harsh Chauhan]

    China’s booming video gaming industry has turned out to be a big moneymaker for NetEase (NASDAQ:NTES) in recent years. From operatingActivision’s popular games such as World of Warcraft and Diablo to building a solid portfolio of self-developed mobile games, NetEase has kept its finger on the pulse of the video gaming market to clock terrificgrowth.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

  • [By Lisa Levin]

    NetEase, Inc. (NASDAQ: NTES) is expected to post quarterly earnings at $2.19 per share on revenue of $2.18 billion.

    China Distance Education Holdings Limited (NYSE: DL) is estimated to post earnings for its second quarter.

  • [By Joseph Griffin]

    Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

    Get NetEase alerts:

    Marvel Introduces Their First Official Chinese Superheroes (huffingtonpost.com) NetEase, Inc. (NTES) year to date performance remained at -22.66% (nasdaqfortune.com) Marvel get its first official Chinese superheroes (bbc.co.uk) Why to Follow this Stock? NetEase, Inc. (NTES) (nysestocks.review) Marvel’s first Chinese superheroes are comingand here are their superpowers (quartzy.qz.com)

    A number of research firms recently weighed in on NTES. BidaskClub cut NetEase from a “hold” rating to a “sell” rating in a report on Tuesday, March 27th. Jefferies Group reduced their price target on NetEase from $335.00 to $310.00 and set a “hold” rating for the company in a report on Tuesday, April 10th. CLSA raised NetEase from a “sell” rating to an “underperform” rating in a report on Thursday, February 8th. Zacks Investment Research raised NetEase from a “sell” rating to a “hold” rating in a report on Thursday, March 8th. Finally, JPMorgan Chase began coverage on NetEase in a report on Thursday, April 12th. They issued an “underweight” rating and a $240.00 price target for the company. Five research analysts have rated the stock with a sell rating, four have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. NetEase currently has a consensus rating of “Hold” and a consensus price target of $337.47.

Top 10 Medical Stocks To Invest In 2019: Stage Stores, Inc.(SSI)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.Stonemor Partners LP (STON) – 6,650,613 shares, 68.21% of the total portfolio. Shares added by 8.91%Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 21.11% of the total portfolio. Stage Stores Inc (SSI) – 1,750,000 shares, 6.3% of the total portfolio. Shares added by 75.00%Five Star Senior Living Inc (FVE) – 2,039,878 shares, 4.38% of the total portfolio. Added

Top 10 Medical Stocks To Invest In 2019: Internet Initiative Japan Inc.(IIJI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Internet Initiative Japan (IIJI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In 2019: Magyar Bancorp Inc.(MGYR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media headlines about Magyar Bancorp (NASDAQ:MGYR) have been trending somewhat positive on Friday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Magyar Bancorp earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned media headlines about the bank an impact score of 48.0770691063571 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Top 10 Medical Stocks To Invest In 2019: S&P GSCI(GD)

Advisors’ Opinion:

  • [By ]

    Cramer and Moreno also looked at General Dynamics (GD) which peaked in early March, before starting a downtrend until Tuesday. Last week, General Dynamics fell to the lower end of its channel, but then it bounced right to the high end, and Wednesday it firmly broke out above the high end of this channel. The stochastic oscillator, which is a powerful momentum indicator is making a bullish crossover, and based on today’s move, Moreno thinks General Dynamics can return to its old highs at $230.

  • [By ]

    In addition to increasing the dividend, Action Alerts PLUS holding Raytheon announced in late March that under the Department of Defense’s DARPA program, it was developing technology that could control swarms of both air-based, and ground-based drone vehicles that might be launched using a “drag and drop” visual interface. My price target: $245.

    General Dynamics (GD)

    This is one firm where we have already seen cash flows and margins improving. GD is also another defense name that increased their dividend in March. Think the Navy gets some love in the 2018 federal budget that earmarked $654 billion for the Pentagon? Me too. Know who runs the Virginia class submarine program? General Dynamics. In fact, the Navy just awarded a $696 million modification to that program for 2019.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Reuben Gregg Brewer]

    Shipbuilding and services specialistHuntington Ingalls (NYSE:HII) was spun off from Northup Grumman in early 2011. General Dynamics (NYSE:GD) is roughly six times larger and offers a far more diversified list of products and services that includes submarines, aircraft, and armored vehicles, among other things. Both, however, provide key products and services to the U.S. military. That’s normally a fairly consistent business driven by large and often very long contracts. With a supportive administration in the White House, it would seem like now is a good time to take a look at this pair of stocks. But which of these two military-industrial companies is a better buy? Using a Benjamin Grahamlens, the answer may not be what you want to hear.

  • [By ]

    Only 10% of the companies on the list had female CEOs at the helm, four of which — Hewlett Packard (HP) , Lockheed Martin (LMT) , General Motors (GM) , and General Dynamics (GD) — grew significant revenue in five years or less. 

  • [By Lee Jackson]

    This company, like other major defense prime contractors, had a very solid year and is also on the Merrill Lynch US 1 list.General Dynamics Corp. (NYSE: GD) is engaged in business aviation, land and expeditionary combat vehicles and systems, armaments, munitions, shipbuilding and marine systems, and information systems and technologies.

Top 10 Medical Stocks To Invest In 2019: Boot(h)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Hyatt Hotels (NYSE:H) Q1 2018 Earnings Conference CallMay. 3, 2018 11:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Shares of Hyatt (NYSE:H) have received a consensus recommendation of “Buy” from the eighteen analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and ten have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $80.42.

Top 10 Medical Stocks To Invest In 2019: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

Top 10 Medical Stocks To Invest In 2019: P.T. Telekomunikasi Indonesia Tbk.(TLK)

Advisors’ Opinion:

  • [By Max Byerly]

    Telekomnks Indn Prsr Tbk Prshn Prsrn (NYSE:TLK) was upgraded by equities research analysts at Macquarie from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports.

  • [By Lisa Levin]

    Tuesday afternoon, the telecommunication services shares climbed 1.18 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 7 percent, and Telekomnks Indn Prsr Tbk Prshn Prsrn-ADR (NYSE: TLK), up 3 percent.

Top 10 Medical Stocks To Invest In 2019: Covenant Transportation Group, Inc.(CVTI)

Advisors’ Opinion:

  • [By Shane Hupp]

    ValuEngine upgraded shares of Covenant Transport (NASDAQ:CVTI) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday morning.

  • [By Shane Hupp]

    Old Dominion Freight Line (NASDAQ: ODFL) and Covenant Transport (NASDAQ:CVTI) are both transportation companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Top 10 Medical Stocks To Own For 2018

The state of New York just made a huge leap forward with medical marijuana – and the U.S. Department of Veteran Affairs, or VA, is not happy about it.

But it doesn’t matter. The VA stands no chance against medical marijuana’s insane trajectory.

Over the weekend, NY Gov. Andrew Cuomo signed new legislation that allows those in the state with post-traumatic stress disorder (PTSD) to use marijuana to treat symptoms. The bill has been touted as a boon for veterans in particular.

“Our veterans risked their lives in order to defend the ideals and principles that this nation was founded upon, and it is our duty to do everything we can to support them when they return home,” said Cuomo, according to The Associated Press.

New York is the 28th state to legalize medical marijuana for PTSD, and this legislation is in direct opposition to the VA’s negative stance on weed.

Never miss a single marijuana industry update again. To get real-time news sent directly to your inbox,sign up with one click here.

Top 10 Medical Stocks To Own For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Medical Stocks To Own For 2018: Invesco Municipal Opportunity Trust(VMO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Invesco Van Kampen Municpl Opprtnty Trst (NYSE:VMO) declared a monthly dividend on Tuesday, April 3rd, Wall Street Journal reports. Shareholders of record on Tuesday, April 17th will be paid a dividend of 0.0554 per share by the investment management company on Monday, April 30th. This represents a $0.66 dividend on an annualized basis and a dividend yield of 5.66%. The ex-dividend date of this dividend is Monday, April 16th.

Top 10 Medical Stocks To Own For 2018: Treehouse Foods, Inc.(THS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Peel Hunt reaffirmed their buy rating on shares of Tharisa (LON:THS) in a research report released on Tuesday morning. They currently have a GBX 230 ($3.12) price target on the stock.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)
  • [By Paul Ausick]

    Treehouse Foods Inc. (NYSE: THS) fell about 15.5% Thursday to post a new 52-week low of $36.35 after closing at $43.01 on Wednesday. The 52-week high is $90.42. Volume of about 4.8 million was more than four times the daily average. The food processing company posted poor results this morning and announced that it is closing one of its plants.

Top 10 Medical Stocks To Own For 2018: Maximus, Inc.(MMS)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
    AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
    Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
    Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
    Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
    Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
    Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
    Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
    ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
    Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
    Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
    Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
    NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
    World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
    MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
    Choice Hotels International, Inc. (NYSE: CH
  • [By Shane Hupp]

    Maximus (NYSE:MMS) updated its FY18 earnings guidance on Thursday. The company provided EPS guidance of $3.30-3.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.49. The company issued revenue guidance of $2.4-2.44 billion, compared to the consensus revenue estimate of $2.50 billion.

  • [By Logan Wallace]

    Maximus (NYSE:MMS) had its price target decreased by Canaccord Genuity from $65.00 to $64.00 in a research report sent to investors on Friday. Canaccord Genuity currently has a hold rating on the health services provider’s stock.

Top 10 Medical Stocks To Own For 2018: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By Todd Campbell]

    Because statins are so widely used, they’re the most prescribed medicines in the world, and that’s been a bonanza for companies like Pfizer (NYSE:PFE), which developed top-selling cholesterol drug Lipitor, and Merck & Co. (NYSE:MRK), which created cholesterol-lowering add-on therapy Zetia.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Merck & Co., Inc. (NYSE: MRK) which rose about 6% to $62.19. The stocks 52-week range is $53.63 to $66.80. Volume was 43 million compared to its average volume of 12.3 million.

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) traded up 1.80% at $58.64. The stock’s 52-week range is $53.63 to $66.80. Volume was about 25% below the daily average of around 12.1 million shares. The company had no specific news.

  • [By ]

    Merck (NYSE: MRK) has also battled falling sales for its Hyzaar drug but could see renewed interest in the diuretics medication for hypertension patients. Sales in 2017 were $484 million compared to annual revenue of nearly $2 billion before the patent expiration in 2011.

  • [By JJ Kinahan]

    Earnings season slows down a little bit next week, although there are still quite a few major reports on tap:

    Pfizer Inc. (NYSE: PFE) and Merck & Co., Inc. (NYSE: MRK) both report before the open on Tuesday, May 1
    Apple Inc. (NASDAQ: AAPL) reports after the close on Tuesday, May 1
    Tesla Inc. (NASDAQ: TSLA) reports after the close on Wednesday, May 2
    Alibaba Group Holding Inc. (NYSE: BABA) reports before the open on Friday, May 4

    Next week the Fed will also be meeting on May 1-2. There isn’t expected to be a whole lot new coming out of that meeting and there’s a 93 percent probability the Fed won’t hike rates, according to the CME FedWatch tool. If you have time, check out today’s market update for a look at what else is going on.

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) traded down 2.27% at $55.01. The stock’s 52-week range is $53.36 to $66.80. Volume was around 9.66 million shares, about 20% lower than the daily average of about 13 million. The company saw a $2.5 billion award disappear as a judge tossed the verdict against Gilead related to a hepatitis treatment.

Top 10 Medical Stocks To Own For 2018: Navios Maritime Holdings Inc.(NM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Navios Maritime Holdings Inc. (NYSE: NM) is estimated to report quarterly loss at $0.23 per share on revenue of $128.00 million.

    Virtusa Corporation (NASDAQ: VRTU) is projected to report quarterly earnings at $0.55 per share on revenue of $279.85 million.

  • [By Joseph Griffin]

    Navios Maritime (NYSE: NM) is one of 44 public companies in the “Deep sea foreign transportation of freight” industry, but how does it contrast to its peers? We will compare Navios Maritime to similar companies based on the strength of its earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Navios Maritime (NM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2018: Marcus Corporation (MCS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Marcus (NYSE: MCS) and AMC Entertainment (NYSE:AMC) are both consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.

  • [By Max Byerly]

    In other news, VP Thomas F. Kissinger sold 10,000 shares of Marcus stock in a transaction dated Wednesday, March 7th. The stock was sold at an average price of $29.12, for a total value of $291,200.00. Following the transaction, the vice president now owns 81,664 shares in the company, valued at $2,378,055.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Diane M. Gershowitz sold 12,750 shares of the firm’s stock in a transaction dated Friday, April 6th. The stock was sold at an average price of $30.86, for a total value of $393,465.00. Following the completion of the sale, the director now directly owns 7,482 shares in the company, valued at $230,894.52. The disclosure for this sale can be found here. Insiders have sold 44,250 shares of company stock valued at $1,343,255 in the last three months. 32.88% of the stock is owned by corporate insiders.

    ILLEGAL ACTIVITY WARNING: “Barrington Research Brokers Lower Earnings Estimates for Marcus Co. (MCS)” was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3367299/barrington-research-brokers-lower-earnings-estimates-for-marcus-co-mcs.html.

    Marcus Company Profile

  • [By Ethan Ryder]

    AMC Entertainment (NYSE: AMC) and Marcus (NYSE:MCS) are both consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Top 10 Medical Stocks To Own For 2018: Innodata Inc.(INOD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Innodata (NASDAQ:INOD) will be releasing its Q1 2018 earnings data before the market opens on Tuesday, May 8th.

    Innodata (NASDAQ:INOD) last announced its earnings results on Thursday, March 8th. The technology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $15.66 million for the quarter. Innodata had a negative return on equity of 10.94% and a negative net margin of 8.30%.

Top 10 Medical Stocks To Own For 2018: Brown Forman Corporation(BF.B)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Brown-Forman (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2018: Simpson Manufacturing Company Inc.(SSD)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Simpson Manufacturing (SSD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Simpson Manufacturing (SSD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Simpson Manufacturing (NYSE:SSD) has been assigned an average rating of “Hold” from the six brokerages that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $64.25.

Best Stocks To Own For 2018

In Moneyball: The Art of Winning an Unfair Game, Michael Lewis shows how smart use of statistics and probability replaced conventional wisdom and gut feelings to transform our national sport through improved strategy. By emphasizing the factors that actually drive victory, performances can be dramatically improved.

In baseball, nobody gets on base every time at bat. But, some players consistently get on base more often than average. Those are the guys you want on your team. If they strike out a couple times in a game, or series, you don’t fire them immediately. Buried within any player’s on base average is a certain amount of randomness that must be endured.

Investing is very much the same. But, before we get too carried away with the analogy, let’s admit up front that baseball depends on raw physical talent to a great extent. Investing presents a far more level playing field where talent is extraordinary rare. So, strategy and execution are proportionally much more important in determining investment results.

Best Stocks To Own For 2018: Pegasystems Inc.(PEGA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Pegasystems (PEGA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    NVIDIA Corporation (NASDAQ: NVDA) is estimated to post quarterly earnings at $1.45 per share on revenue of $2.89 billion.
    News Corporation (NASDAQ: NWSA) is projected to post quarterly earnings at $0.07 per share on revenue of $1.99 billion.
    Symantec Corporation (NASDAQ: SYMC) is estimated to post quarterly earnings at $0.39 per share on revenue of $1.19 billion.
    Pilgrim's Pride Corporation (NASDAQ: PPC) is projected to post quarterly earnings at $0.54 per share on revenue of $2.65 billion.
    Hawaiian Electric Industries, Inc. (NYSE: HE) is expected to post quarterly earnings at $0.38 per share on revenue of $556.81 million.
    Air Lease Corporation (NYSE: AL) is estimated to post quarterly earnings at $1.01 per share on revenue of $383.37 million.
    Flowserve Corporation (NYSE: FLS) is expected to post quarterly earnings at $0.27 per share on revenue of $880.89 million.
    Civitas Solutions, Inc. (NYSE: CIVI) is projected to post quarterly earnings at $0.12 per share on revenue of $396.25 million.
    The Trade Desk, Inc. (NASDAQ: TTD) is estimated to post quarterly earnings at $0.1 per share on revenue of $73.23 million.
    Amdocs Limited (NYSE: DOX) is projected to post quarterly earnings at $0.95 per share on revenue of $980.50 million.
    Yelp Inc. (NYSE: YELP) is estimated to post quarterly loss at $0.04 per share on revenue of $220.14 million.
    Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) is expected to post quarterly earnings at $0.43 per share on revenue of $210.01 million.
    TiVo Corporation (NASDAQ: TIVO) is projected to post quarterly earnings at $0.37 per share on revenue of $198.62 million.
    Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) is expected to post quarterly earnings at $0.17 per share on revenue of $153.87 million.
    Uniti Group Inc. (NASDAQ: UNIT) is estimated to post quarterly earnings at $0.01 per share on revenue of $247.16 million.
    Jagged Peak En

  • [By Demitrios Kalogeropoulos]

    Pegasystems(NASDAQ:PEGA) announced first-quarter results this week that paired a significant slowdown in sales growth with plummeting earnings. The declines were driven by a shift toward cloud-based revenue that had a more pronounced impact on the books because of the implementation of new accounting rules.

  • [By Motley Fool Staff]

    Pegasystems (NASDAQ:PEGA) Q1 2018 Earnings Conference CallMay. 10, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Best Stocks To Own For 2018: Intuitive Surgical Inc.(ISRG)

Advisors’ Opinion:

  • [By ]

    As of the time of this article, home cleaning robot maker iRobot’s (IRBT) shares are down over 6% on the news. And though it makes surgical robots rather than anything meant for homes, Intuitive Surgical  (ISRG) is down close to 2%. As usual, Wall Street immediately trembles on any sign that Amazon plans to further expand its reach.

  • [By Motley Fool Staff]

    Stock No. 4: Let’s go to the “I” stock from our April stocks a year ago. That’s one of my favorite companies, a stock that I own, and have held for more than a decade, and that would be Intuitive Surgical (NASDAQ:ISRG), the maker of the da Vinci robot, the surgical robot.

  • [By Anders Bylund, Leo Sun, and Demitrios Kalogeropoulos]

    Read on to see why you should forget about bitcoin and Ethereum in favor ofTaiwan Semiconductor(NYSE:TSM),eBay(NASDAQ:EBAY), andIntuitive Surgical(NASDAQ:ISRG) — at least when it comes to serious investments for the long term.

  • [By Motley Fool Staff]

    Stock No. 3: Let’s go back to the well. So, April last year what was the “I?” Quick quiz at home? That’s right. It was Intuitive Surgical(NASDAQ:ISRG). I own the company, and in front of my gathered fellow Heels last week, I put Intuitive Surgical on this list, as well, so I present it for you again today. It reminds us to continue to add to our winners. It was a winner a year ago. It had a three for one stock split, something that I don’t personally care about. I don’t think we should spend a lot of time talking about stock splits. I realize some people think they’re exciting or are confused by them.

  • [By Chris Hill]

    But there was more upbeat news elsewhere, with No. 3 airline United Continental(NYSE:UAL) beating on earnings and freight rail titan CSX(NASDAQ:CSX) delivering record first-quarter numbers. Also on the rapid growth train: Intuitive Surgical(NASDAQ:ISRG), whose da Vinci systems are selling at an impressive rate. And speaking of sales of tech products, the guys close out the episode by explaining why it’s a win-win that Amazon.com(NASDAQ:AMZN) and Best Buy(NYSE:BBY) are joining forces to sell smart TVs.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Intuitive Surgical, Inc. (NASDAQ: ISRG) which rose about 8% to $469.73. The stocks 52-week range is $263.66 to $473.79. Volume was 3.2 million compared to the daily average volume of less than 1 million.

Best Stocks To Own For 2018: Oceaneering International, Inc.(OII)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Oceaneering International (NYSE:OII) warned investors earlier this year that 2018 would be a challenging one. The offshore service and product company also thought that the first quarter would be particularly tough because it’s a seasonally weaker quarter. While itdidn’t go exactly as the company envisioned, the results met its muted expectations overall.

  • [By Ethan Ryder]

    Oceaneering International (NYSE:OII) was the recipient of some unusual options trading activity on Monday. Stock traders purchased 833 put options on the stock. This is an increase of approximately 1,415% compared to the average daily volume of 55 put options.

  • [By Logan Wallace]

    Cypress Energy Partners (NYSE: CELP) and Oceaneering International (NYSE:OII) are both oils/energy companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Oceaneering International (OII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Stocks To Own For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Stocks To Buy For 2018

Eldorado Resorts Inc (NASDAQ:ERI) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Eldorado Resorts Inc is a gaming and hospitality company. It owns and operates gaming facilities located in Ohio, Louisiana, Nevada, Pennsylvania and West Virginia. Eldorado Resorts Inc has a market cap of $2.6 billion; its shares were traded at around $33.90 with a P/E ratio of 39.41 and P/S ratio of 1.74.

For the last quarter Eldorado Resorts Inc reported a revenue of $428.2 million, compared with the revenue of $206.5 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $1.5 billion, an increase of 65% from last year. For the last five years Eldorado Resorts Inc had an average revenue growth rate of 46.3% a year.

The reported diluted earnings per share was $1.09 for the year, an increase of 109.6% from previous year. The Eldorado Resorts Inc had an operating margin of 6.44%, compared with the operating margin of 9.98% a year before. The 10-year historical median operating margin of Eldorado Resorts Inc is 9.14%. The profitability rank of the company is 5 (out of 10).

Top 10 Stocks To Buy For 2018: Navios Maritime Partners LP(NMM)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Navios Maritime Partners (NMM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Elizabeth Balboa]

    Meanwhile, Safe Bulkers, Inc. (NYSE: SB) rose $0.73 throughout the 2016, Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) fell $1.69 and Navios Maritime Partners L.P. (NYSE: NMM) dropped $0.93.

Top 10 Stocks To Buy For 2018: Apache Corporation(APA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer and the AAP team say news and caution are weighing on energy and health-care sectors. Find out what they’re telling their investment club members about Apache (APA) , Cimarex (XEC) , Arconic (ARNC) and Allergan (AGN) with a free trial subscription to Action Alerts PLUS.

  • [By VantagePoint]

    Apache Corporation (NYSE: APA) has been ripping since March 2nd, when it hit a two-year low of $33.60. Since then it's up 25 percent. 

    The three-month chart below shows that this trend is likely to continue. The blue line is generated via VantagePoint's intermarket analysis, and represents a prediction of what APA's moving average will be in three days. The black line is a simple 10-day moving average. Note the bullish crossover that occurred in early March. That was a signal that the stock was entering an uptrend. 

  • [By Chris Lange]

    Apache Corp. (NYSE: APA) fourth-quarter results are scheduled for Thursday. The consensus forecast is for $0.22 in EPS on $1.55 billion in revenue. Shares were trading at $38.11. The consensus price target is $50.43. The 52-week range is $35.70 to $56.51.

  • [By WWW.THESTREET.COM]

    Cramer and the Action Alerts PLUS team say they still believe in their embattled Permian names, Cimarex (XEC) and Apache (APA) , both of which have benefited from a slow rotation in recent weeks. These names can produce and profit here. Schlumberger (SLB) remains best in class and Magellan Midstream Partners just might be the best way to play oil given that the pipelines will be needed to transport the new wave of oil able to be drawn out of the ground from increasingly efficient American producers. Get in on the discussion by getting a free trial subscription to Action Alerts PLUS.

Top 10 Stocks To Buy For 2018: Ballard Power Systems, Inc.(BLDP)

Advisors’ Opinion:

  • [By Jim Robertson]

    With that in mind, I would add any stocks or sectors that benefit directly or indirectly from government subsidies because they are in cool or chosensectors that progressive liberal types worshipe.g. so called green or renewable energy or green technology plays like small capsBallard Power Systems Inc (NASDAQ: BLDP),FuelCell Energy Inc (NASDAQ: FCEL) and Plug Power Inc (NASDAQ: PLUG) along with solarinstallers Vivint Solar Inc (NYSE: VSLR) and Sunrun Inc (NASDAQ: RUN). Then there are thebigger and more globalsolar energy solutions stocks like First Solar, Inc (NASDAQ: FSLR) and SunPower Corporation (NASDAQ: SPWR) that will no doubt be the focus of any energy policy or global warming policy coming out of Washington.

  • [By Peter Graham]

    A long term performance chart shows shares of FuelCell Energy along withsmall cap alternative energy or fuel cell stocks like Ballard Power Systems Inc (NASDAQ: BLDP), Hydrogenics Corporation (NASDAQ: HYGS) and Plug Power Inc (NASDAQ: PLUG) all peaking in 2014 with some signs of stabilization early last yearalong withsome increase this year:

  • [By Lisa Levin]

    Friday afternoon, the non-cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) and Sunoco LP (NYSE: SUN).

  • [By Lisa Levin]

    Thursday afternoon, the energy sector proved to be a source of strength for the market. Leading the sector was strength from Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) and Sunoco LP (NYSE: SUN).

  • [By Peter Graham]

    Small cap fuel cell stock Ballard Power Systems Inc (NASDAQ: BLDP) reportedQ2 2017 earnings after the Wednesday market close as China is poised to lead the adoption of FCEVswith the Companycontinuing to focus on the execution of its China strategy during Q2.Revenuegrew 50% to$26.5 million reflecting growth in both Power Products and Technology Solutions. Power Products platform revenueincreased 29% to $15.2 million while the Technology Solutions platformrevenue increased 93% to$11.3 million primarily reflecting increased work on the stack joint venture, bus and tram programs in China. The net loss was $1.2 million foran improvement of $4.6 million or 79% and cash reserves were $68.1 million as of June 30 for an increase of 65% from the end of Q2 2016. The President/CEO commented:

  • [By Peter Graham]

    A long term performance chart shows shares of Plug Power along withalternative energy or fuel cell stock peers like Ballard Power Systems Inc (NASDAQ: BLDP), FuelCell Energy Inc (NASDAQ: FCEL) and Hydrogenics Corporation (NASDAQ: HYGS) all peaking in 2014 with shares leveling off or just sliding downward moderately over the past year:

Top 10 Stocks To Buy For 2018: EXCO Resources NL(XCO)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

Top 10 Stocks To Buy For 2018: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

Top 10 Stocks To Buy For 2018: Royal Bank Scotland plc (RBS)

Advisors’ Opinion:

  • [By Paul R. La Monica]

    European banks worse off than 2008? Lamensdorf is concerned about the exposure to bad loans (especially energy company debt) held by big banks such as Royal Bank of Scotland (RBS), Credit Suisse (CS) and Deutsche Bank (DB). He’s shorting all three.

  • [By Jonathan Morgan]

    Adidas AG slid 2.9 percent after lowering its profit forecast for 2013. Direct Line Insurance Group Plc lost 2.5 percent as Royal Bank of Scotland Group Plc (RBS) sold a 630 million-pound ($1 billion) stake in the U.K.s biggest car insurer.

  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose

Top 10 Stocks To Buy For 2018: Kelly Services Inc.(KELYA)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
    AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
    Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
    Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
    Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
    Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
    Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
    Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
    ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
    Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
    Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
    Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
    NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
    World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
    MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
    Choice Hotels International, Inc. (NYSE: CH
  • [By Monica Gerson]

    Kelly Services, Inc. (NASDAQ: KELYA) is projected to report its quarterly earnings at $0.28 per share on revenue of $1.35 billion.

    Silver Standard Resources Inc. (USA) (NASDAQ: SSRI) is expected to post a quarterly loss at $0.02 per share on revenue of $96.25 million.

  • [By David Milstead]

    One such outfit is Kelly Services (KELYA). The Troy, Mich., company places temporary employees in a variety of fields, such as law, health care, computing and finance. Although recent job reports have been strong, S&P Capital IQ analyst Michael Jaffe sees employers remaining cautious in their hiring practices and using the kind of temporary workers Kelly specializes in. Jaffe says Kelly is his top pick in the staffing sector, and he rates the stock a strong buy.

Top 10 Stocks To Buy For 2018: Mitsubishi Heavy Industries Ltd (MHVYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.

Top 10 Stocks To Buy For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Stocks To Buy For 2018: The Charles Schwab Corporation(SCHW)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “Credit Suisse Group Trims Charles Schwab (SCHW) Target Price to $60.00” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3356662/credit-suisse-group-trims-charles-schwab-schw-target-price-to-60-00.html.

  • [By Taylor Cox]

    Analyst/Investor Days

    Equifax In Montreal
    LendingTree, Inc (NASDAQ: TREE)
    Iovance Biotherapeutics, Inc (NASDAQ: IOVA)
    The Charles Schwab Corporation (NYSE: SCHW) business update call

    Annual Shareholder Meetings

  • [By Lee Jackson]

    Charles Schwab Corp. (NYSE: SCHW) had a famous investor selling stock this past week. Chairman Charles Schwab continues to sell stock at an orderly pace. This week the iconic discount brokerage executive sold 600,000 shares at prices between $32.50 and $33.75. The total for the trade came to a whopping $20 million.As we have noted in the past, Schwab is past 80 years old and clearly much of his selling over the years has been for estate planning purposes. The shares traded Friday at $35.25, so a fair amount left on the table.

  • [By Shane Hupp]

    Charles Schwab (NYSE:SCHW) had its target price cut by analysts at Credit Suisse Group from $62.00 to $61.00 in a research report issued on Monday. The firm presently has an “outperform” rating on the financial services provider’s stock. Credit Suisse Group’s price target would indicate a potential upside of 10.63% from the company’s current price.

  • [By Jordan Wathen]

    It may not be obvious, but commission-free trades are more than just a marketing tool for discount brokers; they’re also a way to make money. Charles Schwab(NYSE:SCHW) charges asset managers a fee to make their ETFs and mutual funds commission free, collecting about $0.19 in annual fees for every $100 its clients invest in other companies’ ETFs and mutual funds. Last year, Schwab generated more income ($957 million) from offering such funds to its clients than it earned in commissions ($600 million) on trades its clients actually paid for!

  • [By Todd Shriber, ETF Professor]

    Vanguard's latest fee cuts answer two such moves this year, including one this month, by rival BlackRock, Inc. (NYSE: BLK) and one fee reduction announcement by Charles Schwab Corp (NYSE: SCHW).